Cite
HARVARD Citation
Taylor, P. et al. (2013). OP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study. Annals of the rheumatic diseases. pp. A65-A66. [Online].